BI

BVF Inc Portfolio holdings

AUM $2.47B
1-Year Est. Return 71.28%
This Quarter Est. Return
1 Year Est. Return
+71.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.47B
AUM Growth
-$332M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
50
New
Increased
Reduced
Closed

Top Buys

1
+$72.6M
2
+$60.1M
3
+$47.4M
4
GPCR icon
Structure Therapeutics
GPCR
+$40.1M
5
STOK icon
Stoke Therapeutics
STOK
+$38.9M

Top Sells

1
+$146M
2
+$139M
3
+$92.8M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$75.6M
5
RVMD icon
Revolution Medicines
RVMD
+$47M

Sector Composition

1 Healthcare 99.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XNCR icon
26
Xencor
XNCR
$1.18B
$32.1M 1.3%
2,740,141
FHTX icon
27
Foghorn Therapeutics
FHTX
$251M
$25.9M 1.05%
5,302,000
ANNX icon
28
Annexon
ANNX
$741M
$21.4M 0.87%
7,000,000
RPTX icon
29
Repare Therapeutics
RPTX
$92M
$18.2M 0.74%
10,333,600
AVTX icon
30
Avalo Therapeutics
AVTX
$337M
$17.2M 0.7%
1,355,256
+327,207
CMPX icon
31
Compass Therapeutics
CMPX
$918M
$16.6M 0.67%
+4,750,000
CBIO
32
Crescent Biopharma
CBIO
$236M
$16.5M 0.67%
1,387,863
ELDN icon
33
Eledon Pharmaceuticals
ELDN
$123M
$16.3M 0.66%
6,293,282
TCRX icon
34
TScan Therapeutics
TCRX
$57.3M
$9.51M 0.39%
5,226,074
PEPG icon
35
PepGen
PEPG
$389M
$8.85M 0.36%
+1,915,000
XFOR icon
36
X4 Pharmaceuticals
XFOR
$342M
$7.64M 0.31%
+2,233,742
IMUX icon
37
Immunic
IMUX
$74.8M
$6.75M 0.27%
7,652,972
IMA
38
ImageneBio Inc
IMA
$72.7M
$6.54M 0.27%
802,102
+468,222
MOLN
39
Molecular Partners
MOLN
$162M
$5.02M 0.2%
1,353,968
IVA
40
Inventiva
IVA
$852M
$3.97M 0.16%
686,040
TENX icon
41
Tenax Therapeutics
TENX
$64.7M
$2.58M 0.1%
339,549
EPIX
42
DELISTED
ESSA Pharma
EPIX
$2.23M 0.09%
11,668,473
+2,919,844
SABS icon
43
SAB Biotherapeutics
SABS
$181M
$1.87M 0.08%
932,697
+14,871
FBRX icon
44
Forte Biosciences
FBRX
$268M
$980K 0.04%
65,350
-522,994
ENGNW icon
45
enGene Holdings Warrants
ENGNW
$27.7M
$681K 0.03%
945,402
NCEL
46
NewcelX Ltd
NCEL
$13.3M
$263K 0.01%
14,368
IONS icon
47
Ionis Pharmaceuticals
IONS
$13.1B
– –
-1,913,385
OVID icon
48
Ovid Therapeutics
OVID
$117M
– –
-3,853,818
RAPT icon
49
RAPT Therapeutics
RAPT
$1.02B
– –
-1,154,692
VSTM icon
50
Verastem
VSTM
$724M
– –
-3,404,425
1
2